Search - tctmd.com

Displaying 81 - 100 of 548

Sort: Relevancy | Date

Presentation THT 2025

Impact of Prior Heart Failure Hospitalizations on Long-Term Outcomes Following ICD Implantation and Generator Exchange

Presenter: Midori Torpoco Rivera

February 12, 2025

Presentation THT 2025

Initial Diuretic Strategies and Heart Failure Hospitalization Outcomes: Insights From a Nationwide Community-Based Cohort

Presenter: Anubodh Varshney

February 12, 2025

Presentation THT 2025

Pulmonary Artery Diastolic Pressure Is Lower in Women Than Men Preceding and at the Time of Heart Failure Hospitalization

Presenter: JoAnn Lindenfeld

February 12, 2025

News Conference News THT 2025

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Todd Neale

February 11, 2025

Presentation THT Abstracts 2025

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

Presenter: Kivanc Ozonat

February 11, 2025

News Daily News

CVD Hospitalization in Older Adults Higher in US Than in Denmark

Michael O'Riordan

February 07, 2025

News Daily News

NT-proBNP Cutoffs for HFpEF Diagnosis May Need Tweaking

Todd Neale

January 29, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Michael O'Riordan

January 13, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

L.A. McKeown

December 05, 2024

News Daily News

Palliative Care in HF: Practical Advice From the HFSA

Caitlin E. Cox

December 05, 2024

News Conference News AHA 2024

Novel AI-Based, Noninvasive Sensor Can Accurately Measure PCWP in HFrEF

Yael L. Maxwell

November 25, 2024

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Conference News AHA 2024

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

L.A. McKeown

November 22, 2024

News Conference News AHA 2024

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Yael L. Maxwell

November 20, 2024

News Conference News AHA 2024

Nasal Bumetanide Safe, Effective in Healthy Adults

Yael L. Maxwell

November 18, 2024

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Todd Neale

November 13, 2024

Advertisement

Impact of Prior Heart Failure Hospitalizations on Long-Term Outcomes Following ICD Implantation and Generator Exchange

Initial Diuretic Strategies and Heart Failure Hospitalization Outcomes: Insights From a Nationwide Community-Based Cohort

Pulmonary Artery Diastolic Pressure Is Lower in Women Than Men Preceding and at the Time of Heart Failure Hospitalization

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

CVD Hospitalization in Older Adults Higher in US Than in Denmark

NT-proBNP Cutoffs for HFpEF Diagnosis May Need Tweaking

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

December 2024 Dispatch for the CV Team

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

Palliative Care in HF: Practical Advice From the HFSA

Novel AI-Based, Noninvasive Sensor Can Accurately Measure PCWP in HFrEF

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Nasal Bumetanide Safe, Effective in Healthy Adults

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content